The present invention includes a medicinal drug comprising an Axonopus
extract and Ludwigia extract dissolved in a pharmacologically acceptable
solvent. The extract is able to reduce the production of pro-inflammatory
cytokines and the proliferation of lymphocytes. The present invention
also includes a method of treating inflammation with the extract.